Related Experiment Videos
Novel mechanisms mediating stunned myocardium
Song-Jung Kim1, Christophe Depre, Stephen F Vatner
1Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103, USA.
Heart Failure Reviews
|May 27, 2003
Summary
Myocardial stunning, prolonged heart dysfunction after ischemia, differs between rodent and large mammal models. Large mammals show broad gene regulation, suggesting survival pathways, unlike rodent models.
Area of Science:
- Cardiology
- Physiology
- Molecular Biology
Background:
- Myocardial stunning is prolonged contractile dysfunction post-ischemia without necrosis.
- It's a key feature of hibernating myocardium in coronary artery disease.
- Understanding its pathogenesis is crucial for therapeutic development.
Purpose of the Study:
- To investigate the differing mechanisms of myocardial stunning in rodent versus large mammalian models.
- To explore the role of calcium (Ca2+) handling and gene regulation in myocardial stunning.
- To identify potential therapeutic targets for myocardial stunning.
Main Methods:
- Utilized various experimental approaches and animal models (rodents to large mammals).
- Focused on testing hypotheses related to oxygen radicals, Troponin I degradation, and Ca2+ handling.
- Employed a large mammalian swine model to study Ca2+ transients and L-type Ca2+ current density.
Main Results:
- Significant differences in relaxation function and phospholamban phosphorylation were observed between models.
- Troponin I degradation, seen in rodents, was absent in stunned swine myocardium.
- Large mammalian models revealed broad gene and protein regulation changes, including upregulation of survival genes.
Conclusions:
- Myocardial stunning mechanisms vary significantly between rodent and large mammalian models.
- Large mammalian models offer a more comprehensive understanding of myocardial stunning pathogenesis.
- These findings provide insights for developing novel therapeutic strategies for myocardial stunning.